A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : pMCAO / permanent MCAO

[Related PubMed/MEDLINE]
Total Number of Papers: 22
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   pMCAO  (>> Co-occurring Abbreviation)
Long Form:   permanent MCAO
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2019 Pathological Comparisons of the Hippocampal Changes in the Transient and Permanent Middle Cerebral Artery Occlusion Rat Models. ---
2019 Salidroside Reduces Inflammation and Brain Injury After Permanent Middle Cerebral Artery Occlusion in Rats by Regulating PI3K/PKB/Nrf2/NFkappaB Signaling Rather than Complement C3 Activity. tMCAO
2018 The Sigma-1 Receptor Antagonist, S1RA, Reduces Stroke Damage, Ameliorates Post-Stroke Neurological Deficits and Suppresses the Overexpression of MMP-9. MCAO, MMP-9, NMDAR, sigma1R
2016 Cerebrovascular Safety of Sulfonylureas: The Role of KATP Channels in Neuroprotection and the Risk of Stroke in Patients With Type 2 Diabetes. MCAO, OGD, STZ, T2DM
2016 Transarterial regional hypothermia provides robust neuroprotection in a rat model of permanent middle cerebral artery occlusion with transient collateral hypoperfusion. CS, ICA, tCHP, tMCAO, WS
2015 Lipocalin-2 released in response to cerebral ischaemia mediates reperfusion injury in mice. LCN2, tMCAO
2014 Immune cell infiltration in malignant middle cerebral artery infarction: comparison with transient cerebral ischemia. MCAO, tMCAO
2013 Mechanisms of enhanced basal tone of brain parenchymal arterioles during early postischemic reperfusion: role of ET-1-induced peroxynitrite generation. ET-1, ETB, PAs, tMCAO
2013 Nanoparticles accumulate in ischemic core and penumbra region even when cerebral perfusion is reduced. tMCAO
10  2013 Stem cells from human exfoliated deciduous tooth-derived conditioned medium enhance recovery of focal cerebral ischemia in rats. DPSC, MCAO, NPC, SHED
11  2012 Long-lasting neuroprotection and neurological improvement in stroke models with new, potent and brain permeable inhibitors of poly(ADP-ribose) polymerase. ---
12  2012 Post-ischemic estradiol treatment reduced glial response and triggers distinct cortical and hippocampal signaling in a rat model of cerebral ischemia. MCAO
13  2012 Stereotactic coordinates for intracerebroventricular infusion after permanent focal cerebral ischemia in Wistar rats. i.c.v, mBS, mNSS, t-MCAO
14  2012 Therapeutic effects of tetramethylpyrazine nitrone in rat ischemic stroke models. MCAO
15  2011 MP-124, a novel poly(ADP-ribose) polymerase-1 (PARP-1) inhibitor, ameliorates ischemic brain damage in a non-human primate model. MCAO, PARP-1, tMCAO, TTW
16  2010 Neuroprotective properties of prostaglandin I2 IP receptor in focal cerebral ischemia. MCA, NDS, WT
17  2009 Effects of cerebral ischemia on neuronal hemoglobin. Hb, IPC, MCAO, OGD
18  2007 Comparison between coated vs. uncoated suture middle cerebral artery occlusion in the rat as assessed by perfusion/diffusion weighted imaging. ADC, CBF, MCAO, TTC
19  2007 Progesterone inhibits ischemic brain injury in a rat model of permanent middle cerebral artery occlusion. PROG
20  2006 Delayed treatment with nicotinamide inhibits brain energy depletion, improves cerebral microperfusion, reduces brain infarct volume, but does not alter neurobehavioral outcome following permanent focal cerebral ischemia in Sprague Dawley rats. MCAO, NAM
21  2004 Nuclear factor-kappaB contributes to infarction after permanent focal ischemia. MCAOs, NF-kappaB, PDTC
22  1998 Ischemic preconditioning and brain tolerance: temporal histological and functional outcomes, protein synthesis requirement, and interleukin-1 receptor antagonist and early gene expression. IT, MCAO, PC